Panczel, I.; Acs, M.; Herold, M.; Madar-Dank, V.; Piso, P.; Schlitt, H.J.; Dank, M.; Szasz, A.M.; Herold, Z.
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2024, 25, 7495.
https://doi.org/10.3390/ijms25137495
AMA Style
Panczel I, Acs M, Herold M, Madar-Dank V, Piso P, Schlitt HJ, Dank M, Szasz AM, Herold Z.
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2024; 25(13):7495.
https://doi.org/10.3390/ijms25137495
Chicago/Turabian Style
Panczel, Ivan, Miklos Acs, Magdolna Herold, Viktor Madar-Dank, Pompiliu Piso, Hans Jürgen Schlitt, Magdolna Dank, Attila Marcell Szasz, and Zoltan Herold.
2024. "Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis" International Journal of Molecular Sciences 25, no. 13: 7495.
https://doi.org/10.3390/ijms25137495
APA Style
Panczel, I., Acs, M., Herold, M., Madar-Dank, V., Piso, P., Schlitt, H. J., Dank, M., Szasz, A. M., & Herold, Z.
(2024). Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 25(13), 7495.
https://doi.org/10.3390/ijms25137495